Wednesday - April 15, 2026

Degenerative Disc Disease Clinical Trial Analysis 2026: Recent FDA Clearances, Ongoing Clinical Studies, and Emerging Treatment Landscape by DelveInsight | Mesoblast, DiscGenics, Biosplice Therapeutic

Degenerative Disc Disease Pipeline According to DelveInsight’s evaluation, the global Degenerative Disc Disease (DDD) pipeline comprises more than 15 prominent companies actively advancing over 15 therapeutic candidates. The analysis encompasses clinical trials, therapeutic approaches, mechanisms of action, routes of administration, … Continue reading

Juvenile Idiopathic Arthritis Market Set for Robust Expansion Through 2036 Driven by Innovative Biologics and Precision Therapies | DelveInsight

Juvenile Idiopathic Arthritis Market The Juvenile Idiopathic Arthritis market is entering a transformative phase, driven by rapid advancements in targeted therapeutics, increasing disease awareness, and improved diagnostic capabilities. Leading pharmaceutical companies such as Bristol-Myers Squibb, UCB Biopharma, Novartis, AbbVie, Sanofi, … Continue reading

Pridopidine Market Forecast to 2034: Strong Clinical Momentum and ALS Expansion to Drive Pridopidine Sales Growth | DelveInsight

Pridopidine Sales Market Forecast The global Pridopidine market is gaining significant traction as Prilenia Therapeutics advances its investigational therapy across Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS). Backed by robust clinical evidence, strategic collaborations, and regulatory advantages, Pridopidine sales … Continue reading

Pulmonary Arterial Hypertension pipeline is witnessing global growth, with over 55 therapies currently under development, according to DelveInsight’s market intelligence report.

Pulmonary Arterial Hypertension pipeline Pulmonary Arterial Hypertension companies, including Aerovate Therapeutics, Novartis, Keros Therapeutics, Vigonvita Life Sciences, Insmed Incorporated, Chugai Pharmaceutical, Merck Sharp & Dohme, Janssen Pharmaceutical, Actelion, Gossamer Bio, Lung Biotechnology PBC, United Therapeutics, Gilead Sciences, Acceleron Pharma, Eiger … Continue reading

Balloon Valvuloplasty Device Market is projected to expand at a CAGR of 5.13% through 2032, fueled by the increasing prevalence of cardiovascular diseases states DelveInsight

Balloon Valvuloplasty Device Market Balloon valvuloplasty device manufacturers consist of BD, PFM Medical AG, NuMED, Balton, TORAY INDUSTRIES, INC., Translumina, InterValve Medical, Inc., OSYPKA AG, SURETECH MEDICAL INC., simeks, among others. The Global Balloon Valvuloplasty Device Market is expected to … Continue reading